(Q45888825)

17 December 2017

review article

1 reference

title

EBV specific CTL: a model for immune therapy (English)

1 reference

17 December 2017

1 reference

Rooney CM

1 reference

17 December 2017

Malcolm Brenner

series ordinal

object named as

Brenner MK

1 reference

17 December 2017

Helen Heslop

series ordinal

object named as

Heslop HE

1 reference

17 December 2017

publication date

1 January 1998

1 reference

17 December 2017

published in

Vox Sanguinis

1 reference

17 December 2017

volume

74 Suppl 2

1 reference

17 December 2017

page(s)

497-498

1 reference

17 December 2017

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1998.TB05463.X

Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1998.TB05463.X

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1998.TB05463.X

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1998.TB05463.X

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1998.TB05463.X

10.1111/J.1423-0410.1998.TB05463.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017